Organizer & Producer
Day 1 – April 5 2016
| 08:00-9:15 |
Registration | |||||||
| 09:15-09:30 | Greetings | |||||||
| 09:30-10:10 |
|
|||||||
| 10:10-10:20 | Poster Teasers | |||||||
| 10:20-10:50 |  Coffee Break and Poster Session |
|||||||
| 10:50 -12:30 | Hall A | Hall B | Hall C | Hall D | ||||
| The Biology of Pluripotency | Hematopoietic and Mesenchymal Stem Cells | Commercialization of Stem Cells Initiatives | Stem Cell Applications in Neural Degenerative Diseases | |||||
| Chair: Adi Kimchi | Chair: Tsvee Lapidot | Chair: Shai Yarkoni | Chair: Michel Revel | |||||
| 10:50 -11:10 | Cap-Independent Protein Translation Controls Cell Fate Decisions in Human Embryonic Stem Cells Adi Kimchi Weizmann Institute of Science, Israel  |
Metabolic Regulation of Blood and Bone Forming Stem Cells: the Role of ROS and Nitric Oxide Tsvee Lapidot Weizmann Institute of Science, Israel |
Catalyzing Company Development by Exploiting Stem Cell Research Services and Technologies Developed Through Public Private Partnerships – A Danish Perspective Customised Single-Use-Bioreactor for Stem Cell Cultivation Commercialization of Stem Cell Therapy "Cellect Inside" – the Way to Develop Disruptive Technology
The commercialization session will bring together KOLs from Denmark, Belgium, US and Israel to discuss different types of ventures and their adaptability to stem cells technologies: Disruptive technologies, innovative products, services and combinations. Company presentations will be followed by panel discussion on the special features typical to cell (and stem cells in particular) based commercialization
|
Basic Aspects of Translational Issues in Cell Therapy to the CNS Tamir Ben Hur Hadassah Hebrew University Medical Center, Israel |
||||
| 11:10 -11:30 | Using Patients' Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Investigating Inherited Cardiac Pathologies Ofer Binah Technion, Israel |
Vascular Stem Cell Niches Eli Keshet Hadassah Hebrew University Medical Center, Israel |
Intrathecal Transplantation of Human Astrocytes Attenuates Clinical Symptoms in SOD1G93A ALS Rat Model Michal Izrael Kadimastem Ltd., Israel |
|||||
| 11:30 -11:50 | Molecular Mechanisms for Inducing and Resolving Pluripotency Jacob Hanna Weizmann Institute of Science, Israel |
Mesenchymal Stem Cells Sensing Mechanical Cues at Microenvironment Dafna Benayahu Tel Aviv University, Israel |
Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosi Yael Gothelf BrainSTorm-Cell Therapeutics Ltd., Israel |
|||||
| 11:50 -12:10 | Pluripotent Genes and Pediatric Cancer Formation Achia Urbach Bar-Ilan University, Israel |
Transcription-Factors are Driving to Normal and Malignat Stem Cells Roi Gazit Ben-Gurion University of the Negev, Israel |
Enhancement of Hippocampal Neurogenesis in the Adult and Aged Brain via Conditional Manipulations of the Vascular Stem Cell Niche Tamar Licht The Hebrew University of Jerusalem, Israel |
|||||
| 12:10 -12:30 | Complete Nuclear Reprogramming Independently of Pluripotency Yossi Buganim The Hebrew University of Jerusalem, Israel |
Live Imaging of Multipotent Angioblasts Reveals New Mechanisms of Vascular Formation Karina Yaniv Weizmann Institute of Science, Israel |
Comments on Stem cells in ALS therapy Michel Revel Kadimastem Ltd., Israel |
|||||
| 12:30 -12:45 | Annual Meeting of the ISCS | |||||||
| 12:30 -13:30 |  Lunch break |
|||||||
| Hall A | Hall B | Hall C | Hall D | |||||
| Tissue Regeneration and Stem Cells | Stem Cells in Neurobiology | Cancer Immunotherapy | Drug Discovery and Disease Modeling | |||||
| 13:30 -15:10 |
Chair: Raphael Gorodetsky | Chair: Benjamin E. Reubinoff | Chair: Michal Besser | Chair: Arik Hasson | ||||
| 13:30 -13:50 | Treatment with Isolated Subpopulation of Potent Human Derived Expanded Placental Stromal Cells (hPSC) for Mitigation of Radiation Effects and for Regenerative Medicine Raphael Gorodetsky Hadassah Hebrew University Medical Center, Israel |
Human Pluripotent Stem Cells Towards Clinical Applications Benjamin Reubinoff Hadassah Hebrew University Medical Center, Israel |
Adoptive Cell Therapy for Cancer Michal Besser Sheba Medical Center, Israel |
Novel Approach for Personalized Medicine of Rare Diseases Miguel Weil Tel Aviv University, Israel |
||||
| 13:50 -14:10 | The Dark Side of the Force: Mesenchymal Stromal Cells in Cardiac Inflammation and Fibrosis Yoni Leor Sheba Medical Center, Israel |
Molecular and Functional Deficiencies in Fragile X Neurons Derived from Human Embryonic Stem Cells Dalit Ben-Yosef Tel Aviv Sourasky Medical Center, Israel |
Personalized T Cell-Based Immunotherapy Targeting Neoantigens for Advanced Cancer Treatment Cyrille Cohen Bar-Ilan University, Israel |
The Use of Patient-Specific Induced Pluripotent Stem Cell Derived Cardiac Myocytes for Disease Modeling and Drug Screening Naim Shaheen Technion, Israel |
||||
| 14:10 -14:30 | Mesenchymal Stromal Cells and Their Secreted Exosomes Exert Therapeutic Impact in Brain Tumors and Degenerative Diseases va the Delivery of Non-Coding RNAS Chaya Brodie Bar-Ilan University, Israel |
Streamlined Derivation of Cortical Fates From Human Pluripotent Stem Cells Allows Standardized Modeling of Development and Disease Yechiel Elkabetz Tel Aviv University, Israel |
New Genes for Improving Safety and Clinical Efficacy of Adoptive T Cell Transfer in Cancer Immunotherapy Gidi Gross Migal, Israel |
Modeling Neuroendcrinological Disorders Using a Novel iPSC-Based Blood Brain Barrier-on-Chip Gad Vatine Cedars-Sinai Medical Center, USA  |
||||
| 14:30 -14:50 | A Novel Approach for Llung Regeneration by Lung Progenitors Following Clearance of the Lung Niche Chava Rosen Weizmann Institute of Science, Israel |
Life-Long Hippocampal Neurogenesis is Controlled by the Immune System through Unique Brain's Borders: Implications to Age-Related Dementia Michal Schwartz Weizmann Institute of Science, Israel |
Fighting Cancer by Mimicking the Immune System Mira Peled-Kamar Applied Immune Technology (AIT), Israel |
Colony Forming Unites - Endothelial Progenitor Cells (CFU-EPCs) – A Surrogate Marker for Diabetic Retinopathy and High Cardiovascular Mortality Arnon Blum Bar-Ilan University, Israel |
||||
| 14:50 -15:10 | Oral Mucosa Derived Stem Cell Cells: From Basic Science to Translational Studies Sandu Pitaru Tel Aviv University, Israel |
Long Lasting Effect of Mesenchymal Stem Cells in BTBR Autism Model in Mice Danni Offen Tel Aviv University, Israel |
A Novel Method for Enhancing Ex Vivo Expansion of Immunotherapeutic Gamma Delta T Cells Ilan Bank Sheba Medical Center and Gammacell Biotechnologies, Israel |
Identification of Function-Specific Pancreatic Progenitors by Cell-Based Proteomics Yoav Soen Weizmann Institute of Science, Israel |
||||
| 15:10 -15:40 | Coffee Break |
|||||||
| 15:40 -16:20 |
|
|||||||
| 16:20 -16:30 | Poster Teasers | |||||||
| 16:30 -17:30 |  |
|||||||
 |
 |
 |